Collegium Pharmaceutical
COLL
140 hedge funds and large institutions have $771M invested in Collegium Pharmaceutical in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 59 reducing their positions, and 22 closing their positions.
224% more call options, than puts
Call options by funds: $1.74M | Put options by funds: $537K
19% more capital invested
Capital invested by funds: $648M → $771M (+$123M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.63% less ownership
Funds ownership: 107.81% → 107.18% (-0.63%)
7% less funds holding
Funds holding: 150 → 140 (-10)
32% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 59
36% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$18.1M |
| 2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$10.7M |
| 3 |
Charles Schwab
San Francisco,
California
|
+$2.53M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$2.44M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$11.5M |
| 2 |
Renaissance Technologies
New York
|
-$3.55M |
| 3 |
JGC
J. Goldman & Co
New York
|
-$2.68M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.59M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.48M |
COLL Hedge Fund Activity: Q3 2020 in Review
140 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2020, worth a combined $771M — up 19% from $648M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of COLL and 14 opened new positions — a net loss of 8 holders — while 59 trimmed existing stakes and 40 added.
The largest buyer was Avidity Partners Management, opening a new position worth an estimated $18.1M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $11.5M sold.
- 140 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2020, down from 150 in Q2 2020.
- Funds reported $771M of Collegium Pharmaceutical stock for Q3 2020, up 19% quarter-over-quarter.
- 14 funds opened new Collegium Pharmaceutical positions in Q3 2020 and 22 closed out, a net change of -8 holders.
- The largest Collegium Pharmaceutical buyer in Q3 2020 was Avidity Partners Management, an estimated $18.1M added.
- The largest Collegium Pharmaceutical seller in Q3 2020 was Sectoral Asset Management, an estimated $11.5M sold.
Based on aggregated 13F filings for Q3 2020.